These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 10568763

  • 1. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.
    Hemauer A, Gigler A, Searle K, Beckenlehner K, Raab U, Broliden K, Wolf H, Enders G, Modrow S.
    J Med Virol; 2000 Jan; 60(1):48-55. PubMed ID: 10568763
    [Abstract] [Full Text] [Related]

  • 2. Antibody responses in parvovirus B19 infected patients.
    Modrow S, Dorsch S.
    Pathol Biol (Paris); 2002 Jun; 50(5):326-31. PubMed ID: 12116851
    [Abstract] [Full Text] [Related]

  • 3. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.
    Lehmann HW, Kühner L, Beckenlehner K, Müller-Godeffroy E, Heide KG, Küster RM, Modrow S.
    J Clin Virol; 2002 Aug; 25(2):135-43. PubMed ID: 12367647
    [Abstract] [Full Text] [Related]

  • 4. IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen.
    Venturoli S, Gallinella G, Manaresi E, Gentilomi G, Musiani M, Zerbini M.
    J Infect Dis; 1998 Dec; 178(6):1826-9. PubMed ID: 9815244
    [Abstract] [Full Text] [Related]

  • 5. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A, Manaresi E, Zakrzewska K, DeSantis R, Musiani M, Zerbini M.
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [Abstract] [Full Text] [Related]

  • 6. Long term follow up of serostatus after maternofetal parvovirus B19 infection.
    Dembinski J, Eis-Hübinger AM, Maar J, Schild R, Bartmann P.
    Arch Dis Child; 2003 Mar; 88(3):219-21. PubMed ID: 12598382
    [Abstract] [Full Text] [Related]

  • 7. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
    Heegaard ED, Rasksen CJ, Christensen J.
    J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.
    Jones LP, Erdman DD, Anderson LJ.
    J Infect Dis; 1999 Aug; 180(2):500-4. PubMed ID: 10395869
    [Abstract] [Full Text] [Related]

  • 9. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P, Lehmann HW, Knöll A, Dorsch S, Modrow S.
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [Abstract] [Full Text] [Related]

  • 10. Development of antibodies to the nonstructural protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: implications for pathogenesis doubtful.
    Searle K, Schalasta G, Enders G.
    J Med Virol; 1998 Nov; 56(3):192-8. PubMed ID: 9783684
    [Abstract] [Full Text] [Related]

  • 11. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.
    Ennis O, Corcoran A, Kavanagh K, Mahon BP, Doyle S.
    J Clin Virol; 2001 Aug; 22(1):55-60. PubMed ID: 11418353
    [Abstract] [Full Text] [Related]

  • 12. Human parvovirus B19 in Iranian pregnant women: a serologic survey.
    Khameneh ZR, Hanifian H, Barzegari R, Sepehrvand N.
    Indian J Pathol Microbiol; 2014 Aug; 57(3):442-4. PubMed ID: 25118740
    [Abstract] [Full Text] [Related]

  • 13. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait.
    Maksheed M, Pacsa AS, Essa SS, Ahmed MA, Monem RA, Surkouh M.
    Acta Trop; 1999 Oct 15; 73(3):225-9. PubMed ID: 10546839
    [Abstract] [Full Text] [Related]

  • 14. Human parvovirus B19 antibodies induce altered membrane protein expression and apoptosis of BeWo trophoblasts.
    Tzang BS, Chiang SY, Chan HC, Liu CH, Hsu TC.
    Mol Med Rep; 2016 Nov 15; 14(5):4399-4406. PubMed ID: 27748859
    [Abstract] [Full Text] [Related]

  • 15. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
    Kerr S, O'Keeffe G, Kilty C, Doyle S.
    J Med Virol; 1999 Feb 15; 57(2):179-85. PubMed ID: 9892405
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.
    Heinz C, Plentz A, Bauer D, Heiligenhaus A, Modrow S.
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct 15; 243(10):999-1004. PubMed ID: 15906067
    [Abstract] [Full Text] [Related]

  • 17. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.
    Tzang BS, Tsai CC, Tsay GJ, Wang M, Sun YS, Hsu TC.
    Clin Chim Acta; 2009 Jul 15; 405(1-2):76-82. PubMed ID: 19362081
    [Abstract] [Full Text] [Related]

  • 18. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya.
    Elnifro E, Nisha AK, Almabsoot M, Daeki A, Mujber N, Muscat J.
    J Infect Dev Ctries; 2009 Apr 30; 3(3):218-20. PubMed ID: 19759477
    [Abstract] [Full Text] [Related]

  • 19. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?
    Mitchell LA.
    J Med Virol; 2002 Jun 30; 67(2):267-74. PubMed ID: 11992589
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.